IL1RAP expression has been identified on the tumor and stromal cells of multiple tumors [69], promoting an immunosuppressive microenvironment, and its interaction with IL1A/IL1B has also been specifically targeted in a phase 1b clinical trial [70]. The gene discussed is IL1B; the disease is neoplasm.